Factors Associated With Successful Antipsychotic Dose Reduction in Schizophrenia: A Systematic Review of Prospective Clinical Trials and Meta-Analysis of Randomized Controlled Trials

被引：0
作者：
Tani, Hideaki [1 ]
Takasu, Shotaro [1 ]
Uchida, Hiroyuki [1 ]
Suzuki, Takefumi [1 ]
Nagai, Nobuhiro [1 ]
Mimura, Masaru [1 ]
Voineskos, Aristotle [1 ]
Takeuchi, Hiroyoshi [1 ]
Ikai-Tani, Saeko [1 ]
机构：
[1] Ctr Addict & Mental Hlth, Toronto, ON, Canada
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Antipsychotics; Dose Reduction; Maintenance Treatment; Schizophrenia;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
W168
引用
收藏
页码：475 / 475
页数：1
相关论文
共 50 条
  • [41] Effect of cannabidiol on schizophrenia based on randomized controlled trials: A meta-analysis
    Zhang, Shuquan
    Li, Min
    Guo, Zhenhua
    ANNALES MEDICO-PSYCHOLOGIQUES, 2022, 180 (07): : 630 - 638
  • [42] Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials
    Bogers, Jan P. A. M.
    Hambarian, George
    Schmidt, Niels Walburgh
    Vermeulen, Jentien M.
    de Haan, Lieuwe
    SCHIZOPHRENIA BULLETIN, 2023, 49 (01) : 11 - 23
  • [43] Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials
    Aleman, A
    Kahn, RS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (04) : 289 - 293
  • [44] Efficacy and tolerability of lurasidone in schizophrenia: A systematic review and meta-analysis of short-term, randomized, placebo controlled trials
    Hagi, K.
    Nosaka, T.
    Kane, J.
    Correll, C.
    EUROPEAN PSYCHIATRY, 2021, 64 : S157 - S157
  • [45] Mindful exercise versus non-mindful exercise for schizophrenia: A systematic review and meta-analysis of randomized controlled trials
    Li, Jing
    Shen, Jing
    Wu, Guangyao
    Tan, Yang
    Sun, Yueji
    Keller, Evan
    Jiang, Yebin
    Wu, Jianlin
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2018, 32 : 17 - 24
  • [46] Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials
    Kishi, Taro
    Hirota, Tomoya
    Iwata, Nakao
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2013, 263 (08) : 633 - 641
  • [47] Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta- analysis of randomized controlled trials
    Kishi, Taro
    Matsuda, Yuki
    Matsunaga, Shinji
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 419 - 434
  • [48] Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials
    Zheng, Wei
    Yang, Xin-Hu
    Cai, Dong-Bin
    Ungvari, Gabor S.
    Ng, Chee H.
    Wang, Nan
    Ning, Yu-Ping
    Xiang, Yu-Tao
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (05) : 625 - 631
  • [49] Metabolic and cardiovascular effects of antipsychotic drugs. A meta-analysis of randomized controlled trials
    Cassioli, E.
    Calderani, E.
    Lazzeretti, L.
    Ragghianti, B.
    Ricca, V.
    Mannucci, E.
    Rotella, F.
    EUROPEAN PSYCHIATRY, 2020, 63 : S16 - S17
  • [50] Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis
    Ceraso, Anna
    Lin, Jessie Jingxia
    Schneider-Thoma, Johannes
    Siafis, Spyridon
    Heres, Stephan
    Kissling, Werner
    Davis, John M.
    Leucht, Stefan
    SCHIZOPHRENIA BULLETIN, 2022, 48 (04) : 738 - 740
12345